Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Whole exome sequencing of pediatric gastric adenocarcinoma reveals an atypical presentation of Li-Fraumeni syndrome.

Chang VY, Federman N, Martinez-Agosto J, Tatishchev SF, Nelson SF.

Pediatr Blood Cancer. 2013 Apr;60(4):570-4. doi: 10.1002/pbc.24316. Epub 2012 Sep 26.

2.

Tumor protein 53 mutations and inherited cancer: beyond Li-Fraumeni syndrome.

Palmero EI, Achatz MI, Ashton-Prolla P, Olivier M, Hainaut P.

Curr Opin Oncol. 2010 Jan;22(1):64-9. doi: 10.1097/CCO.0b013e328333bf00. Review.

PMID:
19952748
3.

The Li-Fraumeni syndrome: an inherited susceptibility to cancer.

Evans SC, Lozano G.

Mol Med Today. 1997 Sep;3(9):390-5. Review.

PMID:
9302689
4.

Germline TP53 mutations and Li-Fraumeni syndrome.

Varley JM.

Hum Mutat. 2003 Mar;21(3):313-20. Review. Erratum in: Hum Mutat. 2003 May;21(5):551.

PMID:
12619118
5.

EFGR-mutant lung adenocarcinoma and Li-Fraumeni syndrome: report of two cases and review of the literature.

Ricordel C, Labalette-Tiercin M, Lespagnol A, Kerjouan M, Dugast C, Mosser J, Desrues B, Léna H.

Lung Cancer. 2015 Jan;87(1):80-4. doi: 10.1016/j.lungcan.2014.11.005. Epub 2014 Nov 20. Review.

6.

[Li-Fraumeni syndrome].

Frebourg T.

Bull Cancer. 1997 Jul;84(7):735-40. Review. French.

7.

Pediatric cancer and Li-Fraumeni/Li-Fraumeni-like syndromes: a review for the pediatrician.

Giacomazzi CR, Giacomazzi J, Netto CB, Santos-Silva P, Selistre SG, Maia AL, Oliveira VZ, Camey SA, Goldim JR, Ashton-Prolla P.

Rev Assoc Med Bras (1992). 2015 May-Jun;61(3):282-9. doi: 10.1590/1806-9282.61.03.282. Review.

8.

Cancer susceptibility syndromes in children in the area of broad clinical use of massive parallel sequencing.

Kuhlen M, Borkhardt A.

Eur J Pediatr. 2015 Aug;174(8):987-97. doi: 10.1007/s00431-015-2565-x. Epub 2015 May 16. Review.

9.

Brain tumors in Li-Fraumeni syndrome: a commentary and a case of a gliosarcoma patient.

Guidi M, Giunti L, Lucchesi M, Scoccianti S, Giglio S, Favre C, Oliveri G, Sardi I.

Future Oncol. 2017 Jan;13(1):9-12. Epub 2016 Aug 15. Review. No abstract available.

PMID:
27523101
10.

Genomics Study of Gastric Cancer and Its Molecular Subtypes.

Yuen ST, Leung SY.

Adv Exp Med Biol. 2016;908:419-39. doi: 10.1007/978-3-319-41388-4_21. Review.

PMID:
27573784
11.

Beyond the exome: the role of non-coding somatic mutations in cancer.

Piraino SW, Furney SJ.

Ann Oncol. 2016 Feb;27(2):240-8. doi: 10.1093/annonc/mdv561. Epub 2015 Nov 23. Review.

PMID:
26598542
12.

The importance of p53 pathway genetics in inherited and somatic cancer genomes.

Stracquadanio G, Wang X, Wallace MD, Grawenda AM, Zhang P, Hewitt J, Zeron-Medina J, Castro-Giner F, Tomlinson IP, Goding CR, Cygan KJ, Fairbrother WG, Thomas LF, Sætrom P, Gemignani F, Landi S, Schuster-Böckler B, Bell DA, Bond GL.

Nat Rev Cancer. 2016 Apr;16(4):251-65. doi: 10.1038/nrc.2016.15. Review.

PMID:
27009395
13.

The genetics of gastroesophageal adenocarcinoma and the use of circulating cell free DNA for disease detection and monitoring.

Openshaw MR, Richards CJ, Guttery DS, Shaw JA, Thomas AL.

Expert Rev Mol Diagn. 2017 May;17(5):459-470. doi: 10.1080/14737159.2017.1308824. Epub 2017 Mar 30. Review.

PMID:
28306358
14.

Role of non-coding sequence variants in cancer.

Khurana E, Fu Y, Chakravarty D, Demichelis F, Rubin MA, Gerstein M.

Nat Rev Genet. 2016 Feb;17(2):93-108. doi: 10.1038/nrg.2015.17. Epub 2016 Jan 19. Review.

PMID:
26781813

Supplemental Content

Support Center